Camp4 Therapeutics Corporation · NASDAQ:CAMP
Vivo Opportunity Fund Holdings, L.P. reported a 7.40% stake in Camp4 Therapeutics Corporation (Schedule 13G/A)
Event Dec 31, 2025 · Filed Feb 13, 2026
Vivo Opportunity Fund Holdings, L.P. reported a 7.40% stake in Camp4 Therapeutics Corporation, 3,856,991 shares, as a passive investor on Dec 31, 2025. Filed Feb 13, 2026 (Schedule 13G/A).
- Stake
- 7.40%
- Shares
- 3,856,991
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Vivo Opportunity Fund Holdings, L.P. | 7.40% | 3,856,991 |
| Vivo Opportunity, LLC | 7.40% | 3,856,991 |
| Vivo Opportunity Cayman Fund, L.P. | 0.80% | 389,577 |
| Vivo Opportunity Cayman, LLC | 0.80% | 389,577 |
Source
Related
- Camp4 Therapeutics Corporation
- Vivo Opportunity, LLC
- Camp4 Therapeutics Corporation shareholders
- Schedule 13G · Vivo Opportunity, LLC · Sep 17, 2025
- Form 4 · Gold Kelly · Sep 2, 2026
- Form 4 · Schwab Andrew J. · Aug 31, 2026
- Schedule 13D/A · Schwab Andrew J. · Aug 31, 2026
- Form 4 · Schwab Andrew J. · Aug 26, 2026
- Form 4 · Schwab Andrew J. · Aug 21, 2026